| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2004.01.022 |
| P8608 | Fatcat ID | release_n4itsymphnbt5pyel4jmsvm7xe |
| P932 | PMC publication ID | 7131708 |
| P698 | PubMed publication ID | 15098545 |
| P50 | author | Ab Osterhaus | Q354237 |
| Stanley Plotkin | Q7599873 | ||
| Guus Rimmelzwaan | Q55230980 | ||
| Adrianus Boon | Q74374122 | ||
| P2860 | cites work | Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome | Q24655367 |
| Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome | Q27472933 | ||
| Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C. | Q27473073 | ||
| Molecular characterization of a hamster viscerotropic strain of yellow fever virus | Q27473079 | ||
| West Nile Virus Infection in the Golden Hamster (Mesocricetus auratus): A Model for West Nile Encephalitis | Q27487802 | ||
| Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model | Q27489554 | ||
| Characterization of a novel coronavirus associated with severe acute respiratory syndrome | Q28202401 | ||
| Identification of a novel coronavirus in patients with severe acute respiratory syndrome | Q29615907 | ||
| The Genome sequence of the SARS-associated coronavirus | Q29619007 | ||
| Selection of influenza vaccine strains and developing pandemic vaccines. | Q30332305 | ||
| The influenza vaccine licensing process. | Q30332717 | ||
| Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L. | Q33187731 | ||
| Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers | Q33336929 | ||
| Strategies and prospects for vaccination against the hepatitis C viruses | Q33791664 | ||
| Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigens | Q33964519 | ||
| Aetiology: Koch's postulates fulfilled for SARS virus | Q34197103 | ||
| Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates | Q34220503 | ||
| Vaccination against cytomegalovirus | Q34242868 | ||
| Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination | Q34355284 | ||
| The future of rotavirus vaccines | Q34801297 | ||
| Rotavirus vaccines: development, current issues and future prospects | Q34826376 | ||
| Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines. | Q34998726 | ||
| Vaccination: a management tool in veterinary medicine | Q35035668 | ||
| Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity | Q35155049 | ||
| Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery | Q35551800 | ||
| Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA. | Q35705123 | ||
| Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus | Q36690054 | ||
| Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice | Q39416079 | ||
| Vaccine-Induced Immunopathology during Bovine Respiratory Syncytial Virus Infection: Exploring the Parameters of Pathogenesis | Q40133020 | ||
| Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus | Q40133490 | ||
| Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates | Q40579590 | ||
| Live viral vectors: Semliki Forest virus. | Q40637234 | ||
| Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. | Q40666116 | ||
| Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine | Q40927607 | ||
| Development of a mammalian cell (Vero) derived candidate influenza virus vaccine | Q41021315 | ||
| Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines | Q43963173 | ||
| Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment. | Q44602073 | ||
| Immunogenicity of combined hepatitis A and B vaccine in elderly persons | Q44638089 | ||
| Virology: SARS virus infection of cats and ferrets | Q45710579 | ||
| Clonal vaccinia virus grown in cell culture as a new smallpox vaccine | Q45722178 | ||
| RSV bronchiolitis, gammadelta T cells and asthma: are they linked? | Q51688352 | ||
| Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals | Q57081485 | ||
| A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines | Q57081496 | ||
| Virus-based vectors for gene expression in mammalian cells: Coronavirus | Q57989814 | ||
| Varicella vaccine--the first six years | Q73685585 | ||
| Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants | Q74410509 | ||
| Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant | Q78164032 | ||
| Effectiveness of a mass hepatitis A vaccination program in preadolescents | Q78805097 | ||
| Evaluation of a population-based prevention program against influenza among Swiss elderly people | Q94174809 | ||
| P433 | issue | 11-12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Barcelona | Q1492 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1327-1334 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Viral vaccine meeting held in Barcelona, October 25-28, 2003 | |
| P478 | volume | 22 |
Search more.